Dr I. Alasdair Russell
Alasdair completed his Bachelor's degree and PhD at the University of Otago, NZ, looking at the interplay between DNA repair and cancer, using Adenoviruses as a model system. Alasdair then moved to Cambridge, UK in 2008 to take up a Postdoc where the ultimate goal was to reverse engineer breast cancer from healthy patient-derived normal cells, believing that 'if you can build it' then 'you can break it'.
In 2015 Alasdair started Cancer Research UK's first genome editing facility at the CRUK Cambridge Institute, specialising in the innovation and application of CRISPR tools. Alasdair is passionate about using technology to combat the most fundamental of biological questions, specifically where the questions relate to human disease.
Alasdair is an inaugural Editor of The CRISPR Journal (Mary Ann Liebert), a College Research Associate of Wolfson College Cambridge, a regular speaker at Academic, Clinical, Investment or Public events, and part of the SynBio Cell Free group and other Synthetic Biology initiatives at the University of Cambridge.